Here are relevant reports on : clinical-trial-market
-
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029
The global Digital PCR and qPCR market, valued at US$9.4 billion in 2023, stood at US$10.0 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$14.8 billion by the end of the period. Growth in the digital PCR (dPCR) and real-time PCR (qPCR) market can be attributed to factors such as the rising incidence and prevalence of target infectious diseases and genetic disorders, continuous advancements in PCR technologies, the role of PCR in biomarker discovery, and increased use of dPCR and qPCR technologies for point of care (POC) diagnostics.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028
The global cystatin C assay market, valued at US$352 million in 2022, stood at US$377 million in 2023 and is projected to advance at a resilient CAGR of 7.5% from 2023 to 2028, culminating in a forecasted valuation of US$540 million by the end of the period.The growth of this market is majorly driven by the Increasing adoption of POC testing and presence of supportive government policies. However, raising awareness among healthcare providers about the benefits of cystatin C testing can be challenging.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Animal Protein Ingredients Market By Type (Dairy, Egg, Gelatin), Application (Dairy, Clinical Nutrition, Dietetic & Sports Food, Confectionery, Beverages, Meat, Bakery), By Geography: Trends & Forecasts To 2018
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Neuromarketing Tools, Technologies, & Services Market by Tool (Hardware Solution, Software Platform), Technology (EEG & Brainware Monitoring, Biometric & Physiological Monitoring), End Users (Clinical Research, Consumer Research) - Global Forecast to 2030
The neuromarketing tools, technologies, and services market is segmented by tools (hardware solutions like EEG amplifiers, eye-tracking, biometric devices, and software platforms), technologies (EEG & brainwave monitoring, eye-tracking, biometric & physiological monitoring), and end users (commercial & enterprise solutions, consumer research, academic & clinical research, and others). Market estimates are derived through extensive secondary and primary research, applying top-down and bottom-up approaches with data triangulation. The study covers global and regional market dynamics, competitive landscape, and forecasts up to 2030, profiling key players such as Tobii AB, iMotions, EMOTIV, Brain Products, Smart Eye, and others.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Laboratoray Centrifuges Market by Product [Equipment (Microcentrifuge, Ultracentrifuge), Accessories (Tube, Plate)], Platform (Benchtop), Rotor Design (Swinging-bucket), Intended Use (Clinical), Application (Diagnostics), End User (Hospitals) - Global Forecast to 2030
The global laboratory centrifuges market, valued at US$1.53 billion in 2024, stood at US$1.58 billion in 2025 and is projected to advance at a resilient CAGR of 2.8% from 2024 to 2030, culminating in a forecasted valuation of US$1.86 billion by the end of the period. This growth is driven by increased R&D investments and research grants, technological advancements and innovative rotor designs, a rise in infectious diseases that boosts sample testing and cell-based research, and expanding applications of these centrifuges.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030
The global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Laboratory Proficiency Testing Market by Industry (Clinical Diagnostics, Microbiology, Pharmaceutical, Food & Animal Feed, Water, Opioid), Technology (PCR, Cell Culture), and Region; Unmet Needs, Stakeholder & Buying Criteria - Global Forecast to 2028
The global laboratory proficiency testing market, valued at US$1.1 billion in 2022, stood at US$1.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.4% from 2023 to 2028, culminating in a forecasted valuation of US$1.6 billion by the end of the period. The proficiency testing market is projected to experience substantial expansion in the forecasted period due to its mandatory requirement for laboratories operating in various regulated industries like APIAC, CLIA, and CLSI.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The Europe artificial intelligence (AI) in healthcare market is projected to reach USD 31.72 billion by 2030 from USD 6.12 billion in 2025, at a CAGR of 39.0% during the forecast period. The prominent players operating in the Europe artificial intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), and Amazon Web Services, Inc. (US), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the Europe artificial intelligence (AI) in healthcare market.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Clinical Workflow Solutions Market by Product (Data Integration, Nurse Call Systems, Rounding Solutions, Patient Flow Management, Enterprise Reporting), End Users (Hospitals, Long-term Care, Ambulatory Care Centers) & Region - Global Forecast to 2025
The global clinical workflow solutions market growth is primed to transition from USD 9.1 billion in 2020 to USD 18.1 billion by 2025, showcasing a strong CAGR of 14.8%. Growth in this market is driven by the implementation of government initiatives supporting the adoption of HCIT solutions, advantages of clinical workflow solutions in enhancing patient care and safety, increasing patient volume due to the COVID-19 pandemic, growing adoption of EHRs and other HCIT solutions, and the rising need to curtail healthcare costs.
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
